BioSpace News Archive

Element3 Health today announced that millions of Medicare Advantage members nationwide now have access, through their health insurance plans, to the company’s robust network of activity clubs.

While subtle differences in the number of genes copied from one individual and passed down to the next can be found in many healthy people, their role in disease may be much greater than previously thought.

TriAltus Bioscience, LLC, transforming protein-based research, announced its participation and poster presentation at the 19th annual PepTalk: The Protein Science Week.

Ipsen announced the appointment of Dr. Steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance effective March 1, 2020.

Astellas will pay Adaptimmune an upfront payment, research funding, development and commercial milestones, and royalties on net sales on co-commercialized products

Canadian pharmaceutical company JAMP Pharma Group has signed an exclusive agreement with global speciality biopharmaceutical company Alvotech for the Canadian commercial rights to five biosimilars.

Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce a multi target research collaboration with John DiPersio, MD, PhD, Chief of the Division of Oncology at Washington University School of Medicine and Deputy Director of the Alvin J. Siteman Cancer Center in St. Louis.

GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease.

ICON plc, global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced its financial guidance for the year ended December 31, 2020.

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today additional information concerning the presentation of its CoPrimer™ technology by a representative of Bayer – Crop Science yesterday at the International Plant & Animal Genome (PAG) XXVIII conference, including the successful multiplexing of a panel of 15 targets using CoPrimer assays.